Evidence map›Paper›PMID 10097129›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2.

G A Snyder, A G Brooks, P D Sun

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Genetic Variants inFrontiers in immunology · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  11. Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

G A SnyderDepartment of Biochemistry, Molecular Biology, and Cell Biology, 2153 Sheridan, O. T. Hogan Hall, Room 2-100, Northwestern University, Evanston, IL 60208, USA.
A G Brooks
P D Sun
National Institute of Allergy and Infectious Diseases · USUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Killer cell inhibitory receptors (KIR) protect class I HLAs expressing target cells from natural killer (NK) cell-mediated lysis. To understand the molecular basis of this receptor-ligand recognition, we have crystallized the extracellular ligand-binding domains of KIR2DL2, a member of the Ig superfamily receptors that recognize HLA-Cw1, 3, 7, and 8 allotypes. The structure was determined in two different crystal forms, an orthorhombic P212121 and a trigonal P3221 space group, to resolutions of 3.0 and 2.9 A, respectively. The overall fold of this structure, like KIR2DL1, exhibits K-type Ig topology with cis-proline residues in both domains that define beta-strand switching, which sets KIR apart from the C2-type hematopoietic growth hormone receptor fold. The hinge angle of KIR2DL2 is approximately 80 degrees, 14 degrees larger than that observed in KIR2DL1 despite the existence of conserved hydrophobic residues near the hinge region. There is also a 5 degrees difference in the observed hinge angles in two crystal forms of 2DL2, suggesting that the interdomain hinge angle is not fixed. The putative ligand-binding site is formed by residues from several variable loops with charge distribution apparently complementary to that of HLA-C. The packing of the receptors in the orthorhombic crystal form offers an intriguing model for receptor aggregation on the cell surface.

Indexed as

Protein Structure, SecondaryAmino Acid SequenceComputer GraphicsConserved SequenceCrystallography, X-RayHLA-C AntigensHumansImmunoglobulin AllotypesKiller Cells, NaturalModels, MolecularMolecular Sequence DataProlineProtein FoldingReceptors, Colony-Stimulating FactorReceptors, ImmunologicReceptors, KIRHLA-C*03 antigenHLA-C AntigensImmunoglobulin AllotypesKIR2DL2 protein, humanProlineReceptors, Colony-Stimulating FactorReceptors, ImmunologicReceptors, KIRReceptors, KIR2DL1Receptors, KIR2DL2

Identifiers

PMID10097129
PMCPMC22386
OpenAlexW2038712890

What OpenQuestion holds

Texttitle and abstract
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.